BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23945122)

  • 21. Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses.
    Bilezikian JP; Clarke BL; Mannstadt M; Rothman J; Vokes T; Lee HM; Krasner A
    Clin Ther; 2017 Oct; 39(10):2096-2102. PubMed ID: 28942334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption.
    Saraff V; Rothenbuhler A; Högler W; Linglart A
    Horm Res Paediatr; 2018; 89(4):271-277. PubMed ID: 28926829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism.
    Rubin MR; Cusano N; Yin S; Tokareva E; Ayodele O; Finkelman RD
    Endocr Pract; 2024 Mar; 30(3):200-208. PubMed ID: 38086524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.
    Marcucci G; Beccuti G; Carosi G; Cetani F; Cianferotti L; Colao AM; Di Somma C; Duradoni M; Elefante A; Ghizzoni L; Giusti M; Lania AG; Lavezzi E; Madeo B; Mantovani G; Marcocci C; Masi L; Parri S; Pigliaru F; Santonati A; Spada A; Vera L; Brandi ML
    J Endocrinol Invest; 2022 Sep; 45(9):1653-1662. PubMed ID: 35460461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
    Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism.
    Fuss CT; Burger-Stritt S; Horn S; Koschker AC; Frey K; Meyer A; Hahner S
    Endocrinol Diabetes Metab Case Rep; 2020 May; 2020():. PubMed ID: 32478671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
    Bislev LS; Sikjaer T; Rejnmark L
    Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous Subcutaneous Delivery of rhPTH(1-84) and rhPTH(1-34) by Pump in Adults With Hypoparathyroidism.
    Charoenngam N; Bove-Fenderson E; Wong D; Cusano NE; Mannstadt M
    J Endocr Soc; 2024 Mar; 8(5):bvae053. PubMed ID: 38562130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS-1/APECED patients undergoing invasive procedures.
    Winer KK; Schmitt MM; Ferre EMN; Fennelly KP; Olivier KN; Heller T; Lionakis MS
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):377-383. PubMed ID: 32955743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
    Chen KS; Gosmanova EO; Curhan GC; Ketteler M; Rubin M; Swallow E; Zhao J; Wang J; Sherry N; Krasner A; Bilezikian JP
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3557-65. PubMed ID: 32738041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
    Aouchiche K; Reynaud R; Amodru V; Brue T; Cuny T
    Endocrine; 2022 Apr; 76(1):179-188. PubMed ID: 34984624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
    Kim ES; Keating GM
    Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism.
    Shah M; Bancos I; Thompson GB; Richards ML; Kasperbauer JL; Clarke BL; Drake MT; Stan MN
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):822-7. PubMed ID: 26312597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
    Angelopoulos NG; Goula A; Tolis G
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
    Ing SW; Finkelman RD; He P; Khan AA; Mannstadt M; Rejnmark L; Song I; Takács I; Wu Y
    JBMR Plus; 2023 Jul; 7(7):e10758. PubMed ID: 37457880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.
    Ayodele O; Rejnmark L; Mu F; Lax A; Berman R; Swallow E; Gosmanova EO
    Adv Ther; 2022 Nov; 39(11):5013-5024. PubMed ID: 36018496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism.
    Vokes TJ; Mannstadt M; Levine MA; Clarke BL; Lakatos P; Chen K; Piccolo R; Krasner A; Shoback DM; Bilezikian JP
    J Clin Endocrinol Metab; 2018 Feb; 103(2):722-731. PubMed ID: 29099947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving management of severe hypoparathyroidism: a case series.
    Ugalde-Abiega B; Lamas Oliveira C; Alfaro Martínez JJ; Meizoso-Pita O; Sevillano Collantes C; Gomez García I; Perez Rodríguez A; Huguet I
    Hormones (Athens); 2022 Mar; 21(1):71-77. PubMed ID: 34647284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.